Less than 24 hours after researchers received the first genomic sequence of the novel coronavirus that causes COVID-19, scientists began working to identify potential preventative vaccines. Since then, the process to develop these innovative medical products has been on full display.
Already, multiple vaccines and treatments have received emergency use authorization (EUA) for use in the United States. Global health authorities outside the United States have also authorized numerous vaccines. Additionally, in the United States, one antiviral medicine has been approved for the treatment of severe COVID-19 infection. While COVID-19 was unknown to scientists until late 2019, research and development essential to supporting the vaccines and treatments ultimately authorized and approved to treat COVID-19 has been ongoing for several years.